The story of Viagra, and its creator copyright, presents a challenging case study for investors. Initially a blockbuster drug, yielding billions in sales , its patent expiration created a wave of generic competition , significantly eroding its market share . While specific firms may try to capitalize on similar conditions , the present landscape de